605199 Hainan Huluwa Pharmaceutical Group
- 17.18
- +1.56+9.99%
Hainan Huluwa Pharmaceutical Group News
Announcement on abnormal fluctuations in stock trading of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Response to the inquiry letter on abnormal fluctuations in stock trading
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the progress of the financial leasing business of the company and its subsidiaries
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. receiving government subsidies
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on providing guarantees for project loans for holding subsidiaries
Announcement of the Third Interim Resolution of the Third Board of Supervisors of Hainan Huluwa Pharmaceutical Group Co., Ltd. in 2024
Announcement of the fourth interim resolution in 2024 of the third board of directors of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the change of accounting firm
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on obtaining an oseltamivir phosphate capsule drug registration certificate
CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on Hainan Huluwa Pharmaceutical Group Co., Ltd. changing some fund-raising investment projects
Hainan Huluwa Pharmaceutical Group Co., Ltd. Independent Director Nominee Statement
Hainan Huluwa Pharmaceutical Group Co., Ltd. Independent Director Candidate Statement (Wang Bo)
Huluwa: Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on obtaining a drug registration certificate for agatroban injections
Huluwa: Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the wholly-owned subsidiary receiving GMP compliance test results for pharmaceuticals
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on obtaining a drug registration certificate for agatroban injections
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on holding a performance briefing for the third quarter of 2024
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the intention of the company and its subsidiaries to carry out financial leasing business
Hainan Huluwa Pharmaceutical Group Co., Ltd. Public Opinion Management System
Announcement of the second interim resolution in 2024 of the third board of directors of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Huluwa: Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on providing guarantees for wholly-owned subsidiaries
Analysis
Price Target
No Data
No Data